Clinical, Neurophysiological and Radiological Evaluation of Patients With Basal Ganglia Lesions

The recruitment status of this study is unknown because the information has not been verified recently.
Verified September 2005 by Groupe Hospitalier Pitie-Salpetriere.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Groupe Hospitalier Pitie-Salpetriere
ClinicalTrials.gov Identifier:
NCT00169325
First received: September 12, 2005
Last updated: August 27, 2007
Last verified: September 2005
  Purpose

Basal ganglia are involved in the control of motor, cognitive and emotional behaviours. The aim of this study is to precisely evaluate patients with basal ganglia focal lesions both with or without loss of psychic-self activation.


Condition Intervention
Basal Ganglia Lesions
Procedure: Magnetic resonance imaging

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Diagnostic

Resource links provided by NLM:


Further study details as provided by Groupe Hospitalier Pitie-Salpetriere:

  Eligibility

Ages Eligible for Study:   18 Years to 80 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Basal ganglia lesions

Exclusion Criteria:

  • Contraindication to magnetic resonance imaging (MRI)
  • Dementia
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00169325

Contacts
Contact: Bruno Dubois, MD, PhD 33-142161950 b.dubois@psl.aphp.fr
Contact: Andréas Hartmann, MD, PhD 33-142161950 hartmann@ccr.jussieu.fr

Locations
France
Centre d'Investigation Clinique-Hôpital Pitié-Salpetriere Recruiting
Paris, France
Contact: Marie-Laure Welter, MD    33-142161950    marie-laure.welter@psl.aphp.fr   
Contact: Andréas Hartmann, MD, PhD    33-142161950    hartmann@ccr.jussieu.fr   
Principal Investigator: Bruno Dubois, MD, PhD         
Sponsors and Collaborators
Groupe Hospitalier Pitie-Salpetriere
Investigators
Principal Investigator: Bruno Dubois, MD, PhD Groupe Hospitalier Pitié-Salpêtrière
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00169325     History of Changes
Other Study ID Numbers: P031201
Study First Received: September 12, 2005
Last Updated: August 27, 2007
Health Authority: France: Ministry of Health

Keywords provided by Groupe Hospitalier Pitie-Salpetriere:
basal ganglia
loss of psychic self-activation

Additional relevant MeSH terms:
Synovial Cyst
Ganglion Cysts
Cysts
Neoplasms
Mucinoses
Connective Tissue Diseases

ClinicalTrials.gov processed this record on July 31, 2014